Analysis of Pan-Cancer Revealed the Immunological and Prognostic Potential of CBX3 in Human Tumors.

Xu, Haitao; Jiang, Caihong; Chen, Dangui; Wu, Youzhi; Lu, Jia; Zhong, Long; Yao, Fusheng

Xu, Haitao; Jiang, Caihong; Chen, Dangui; Wu, Youzhi; Lu, Jia; Zhong, Long; Yao, Fusheng.

Afiliación

Xu H; Department of Hematology, Anqing Municipal Hospital, Anqing Hospital Affiliated to Anhui Medical University, Anqing, China.
Jiang C; Department of Pediatric Surgery, Anqing Municipal Hospital, Anqing Hospital Affiliated to Anhui Medical University, Anqing, China.
Chen D; Department of Hematology, Anqing Municipal Hospital, Anqing Hospital Affiliated to Anhui Medical University, Anqing, China.
Wu Y; Department of Hematology, Anqing Municipal Hospital, Anqing Hospital Affiliated to Anhui Medical University, Anqing, China.
Lu J; Department of Hematology, Anqing Municipal Hospital, Anqing Hospital Affiliated to Anhui Medical University, Anqing, China.
Zhong L; Department of Hematology, Anqing Municipal Hospital, Anqing Hospital Affiliated to Anhui Medical University, Anqing, China.
Yao F; Department of Hematology, Anqing Municipal Hospital, Anqing Hospital Affiliated to Anhui Medical University, Anqing, China.

Front Med (Lausanne) ; 9: 869994, 2022.

Article en En | MEDLINE | ID: mdl-35573019

Palabras clave

CBX3; MSI; TMB; immune cell infiltration; pan-cancer; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google